Table of Contents
Each Institute of the National Institutes of Health maintains a national advisory council which has two general functions: (1) to advise the Institute on policy and procedures affecting the extramural research programs and (2) to provide a second level of review for all grant and cooperative agreement applications considered by the Institute for funding. Except for fellowships, the NINDS may not award a grant unless it has been recommended for support by the National Advisory Neurological Disorders and Stroke (NANDS) Council.
The NANDS Council meets regularly three times a year: in early February, late May, and mid-September. Each meeting of the NANDS Council is about one and one half days long. A portion of this meeting is open to the public and the remainder is a closed confidential session devoted primarily to the review of applications.
In addition to application review, the NINDS Director utilizes the expertise and experience of NANDS Council members for activities such as the following:
Meeting Dates | Location |
---|---|
February 5-6, 2009 | NIH, Building 31, Conference Room 10 |
May 28-29, 2009 | NIH, Building 31, Conference Room 10 |
September 17-18, 2009 | NIH, Building 31, Conference Room 10 |
February 4-5, 2010 | NIH, Building 31, Conference Room 10 |
May 27-28, 2010 | NIH, Building 31, Conference Room 10 |
September 23-24, 2010 | NIH, Natcher Building, Room E1-E2 (rescheduled from September 16-17, 2010) |
September 18-19, 2008
May 29-30, 2008
February 7-8, 2008
September 20-21, 2007
May 24-25, 2007
February 15-16, 2007
September 14-15, 2006
May 25-26, 2006
February 9-10, 2006
Minutes from Previous Meetings
September 2008
May, 2008
February, 2008
September, 2007
May, 2007
February, 2007
September, 2006
May, 2006
February, 2006
September, 2005
May, 2005
February, 2005
September, 2004
May, 2004
February, 2004
September, 2003
May, 2003
February, 2003
September, 2002
May, 2002
February, 2002
October, 2001
May, 2001
February, 2001
September, 2000
May, 2000
February, 2000
September, 1999
May, 1999
February, 1999
September, 1998
May, 1998
February, 1998
NANDSC Membership Roster
Susan Axelrod (2010)
President and Founder, Citizens United for Research in Epilepsy
Robi Blumenstein (2009)
President, MRSSI
Emery N. Brown, M.D., Ph.D. (2012)
Professor of Health Sciences and Technology and Professor of Computational Neuroscience
Massachusetts Institute of Technology;
Professor of Anaesthesia, Massachusetts General Hospital, Harvard Medical School
Lucie Bruijn, Ph.D. (2010)
Science Director and Vice President, The ALS Association
Ralph G. Dacey, Jr., M.D. (2010)
Professor and Chairman, Department of Neurological Surgery, Washington University
Robert M. Friedlander, M.D. (2012)
Vice Chairman, Department of Neurosurgery
Professor of Neurosurgery
Brigham and Women's Hospital, Harvard Medical School
Katie Hood, M.B.A. (2012)
Chief Executive Officer, The Michael J. Fox Foundation for Parkinson's Research
Edgar Kenton, M.D., (2010)
Expert in Stroke and Neurological Disease, Atlanta, Georgia
Geoffrey S. F., Ling M.D., Ph.D.
Ex Officio Member, Director, Division of Critical Care, Department of Anesthesiology and Critical Care Medicine, USUHS
Helen S. Mayberg, M.D. (2009)
Professor, Psychiatry and Neurology, Emory University School of Medicine
Laura R. Ment, M.D., (2009)
Professor, Departments of Pediatrics and Neurology, Yale University School of Medicine
Luis Parada, Ph.D. (2011)
Professor and Chair, Department of Developmental Biology, University of Texas Southwestern Medical Center
Cindy K. Parseghian (2011)
President, Ara Parseghian Medical Research Foundation
Timothy A. Pedley, M.D. (2011)
Professor and Chair, Department of Neurology, College of Physicians and Surgeons, Columbia University
John Povlishock, Ph.D. (2011)
Professor and Chair, Department of Anatomy and Neurobiology, Virginia Commonwealth University
Louis J. Ptácek, M.D. (2012)
Director, Division of Neurogenetics
John C. Coleman Distinguished Professorship in Neurodegenerative Diseases
Professor, Department of Neurology
University of California, San Francisco
Robert L. Ruff, M.D., Ph.D.
Ex Officio Member, Acting Director, Rehabilitation R&D Service, Veterans Affairs Central Office
Caroline M. Tanner, M.D., Ph.D. (2009)
Director of Clinical Research, The Parkinson's Institute
Gary L. Westbrook, M.D. (2010)
Co-Director, Vollum Institute, Oregon Health and Science University
Vicky Holets Whittemore, Ph.D. (2011)
Director of Science, Tuberous Sclerosis Alliance
Council General Recommendations
The Institute staff may take the following actions without Council review. Council may request information on these actions at any time.
Make research grant awards equal to the anticipated direct cost committed support for continuing work under the same principal investigator when he or she moves from one institution to another. Approval will not be automatic; NINDS staff may consult with the appropriate study section or Council as necessary.
Approve a new or interim principal investigator or program director to continue an active grant.
Take necessary action on extensions of project period end dates without additional funds.
Make awards that appropriately restore years deleted by an initial review group.
Take final action in awarding supplements to the chairpersons of the NINDS research and training review committees in an amount necessary to carry out the functions of the committees.
The Institute may take the following actions without Council review, but will document actions and present them to Council annually for its information.
Make appropriate awards for orderly termination or interim support of competing continuation applications that were either not recommended for further consideration (NRFC) or recommended with a priority score too poor for payment. This procedure is to be used in those cases where sudden termination of the grant would cause a serious loss of scientific material or impose a hardship to already employed personnel. In such cases, (1) the award usually should be for a period of less than twelve months, (2) careful review should be given to the need for salaries and consumable supplies, (3) usually no funds should be provided for additional equipment or travel, and (4) in the case of training grants, stipend support should be provided for completion of training for those trainees already appointed.
Make an award for an appropriate amount and period of time when a recommendation of deferral on a competing continuation application results in a loss of continuity of the active research or training program.
Make supplemental awards or adjustments when additional funds are necessary above the amount previously recommended to carry out the scientific, administrative and fiscal intent of the grant as previously awarded, with the following limitations.
NINDS may obtain expedited council approval in order to allow issuance of awards, where possible, in advance of the formal council meeting. Applications eligible for expedited council review include research project grants (R01s, R03s, R15s, and R21s), research program projects and specialized center grants (P01s, P20s, P30s, and P50s), and cooperative agreements (U01s and U54s) from domestic institutions that fall within the approved payline. (Applications that must be considered by the full Council are ineligible for this expedited process, including clinical trials and other applications that exceed $1,000,000 direct costs per year, applications in response to an RFA, applications in response to a PAS beyond the payline, applications with a human subjects or animal welfare concern, and applications from foreign institutions.) Approximately eight weeks before the council meeting, eligible applications for which percentiles are available will be brought to the attention of a subset of Council members. With the approval of these Council members, NINDS may issue expedited awards for those applications for which all administrative requirements have been satisfactorily met.
Last updated December 03, 2008